OR WAIT 15 SECS
© 2020 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2020 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Jill Wechsler is Pharm Exec's Washington Corespondent
This week's much-anticipated meeting of FDA’s vaccine advisory committee will address critical issues related to the testing and approval of vaccines to prevent COVID-19 infection.
Missteps threaten agency’s independence as vaccines seek finish line.
FDA has published updated Emergency Use Authorization (EUA) requirements for new coronavirus preventives.
Experts fear confusion over allocation process, cold-chain requirements, IT systems.